scispace - formally typeset
J

Jun Ma

Researcher at Harbin Institute of Technology

Publications -  1523
Citations -  58397

Jun Ma is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: Nasopharyngeal carcinoma & Medicine. The author has an hindex of 97, co-authored 1338 publications receiving 39643 citations. Previous affiliations of Jun Ma include Shenyang Aerospace University & University of Technology, Sydney.

Papers
More filters
Journal ArticleDOI

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN).

TL;DR: It is demonstrated that hypermethylation of the UCHL1 promoter leads to its downregulation in NPC, and it is found that UCHL 1 interacts with CTTN, and may function as a ligase promoting C TTN degradation by increasing K48-linked ubiquitination of CTTn.
Journal ArticleDOI

Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

TL;DR: In this article, the extent to which organs at risk (OARs) are spared when using reduced margins in the treatment of nasopharyngeal carcinoma (NPC) was quantified, and two IMRT plans were regenerated for 40 patients with NPC based on two PTV margins, which were reduced or unchanged following cone beam computed tomography online correction.
Journal ArticleDOI

High electrochemical cycling performance through accurately inheriting hierarchical porous structure from bagasse

TL;DR: In this article, a new class of carbon materials whose hierarchical porous structure is accurately inherited from bagasse through a process consisting of a hydrothermal treatment with thiourea at 180°C and then carbonization at 800°C.
Journal ArticleDOI

Start up of a gravity flow CANON-like MBR treating surface water under low temperature

TL;DR: In this paper, the CANON-like MBR system was optimized under different operation conditions such as reflux, sludge retention time, aeration intermediate, hydrogen retention time (HRT), and powder active carbon (PAC) dosing.